Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
TetraGenetics and ImmunoPrecise extend collaboration by signing multi-target service agreement for the Discovery of Therapeutic Antibodies Canada NewsWire VICTORIA, April 9, 2019 VICTORIA , April 9, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") ...
ImmunoPrecise Antibodies ( OTCQB:IPATF ) has formed a wholly-owned, Cambridge, Massachusetts-based subsidiary, Talem Therapeutics (Talem). More news on: Immunoprecise Antibodies Ltd., Healthcare stocks news, Read more ...
ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics Canada NewsWire VICTORIA, April 4, 2019 VICTORIA , April 4, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) a...
April 4, 2019 New York, NY – April 4, 2019 – Timelines on the next generation of antibody discovery may be getting shorter. Potentially incentivized by a new study on the monoclonal antibody therapy market, analysts recently projected a double-digit 10.5% CAGR by 2022, an...
ImmunoPrecise Antibodies Ltd. Announces Trading on OTCQB® Venture Market Canada NewsWire VICTORIA, April 3, 2019 VICTORIA , April 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that i...
ImmunoPrecise Launches DeepDisplay(™) Antibody Discovery Platform Canada NewsWire VICTORIA, April 2, 2019 ImmunoPrecise Launches Large-Scale Discovery Program with US Pharma Company VICTORIA , April 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Compa...
ImmunoPrecise Antibodies ( OTCPK:IPATF ): Q3 net loss of $1.2M More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, , Read more ...
ImmunoPrecise Antibodies Reports Record Q3 2019 Financials Results Canada NewsWire VICTORIA, March 27, 2019 - Revenues Up 228% For The First 9 Months of Fiscal 2019 VICTORIA , March 27, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "ImmunoPrecise") (TSX...
POINT ROBERTS, Wash. and DELTA, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Investorideas.com , a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market ...
ImmunoPrecise Antibodies Announces Resignation of Jos Raats, as Managing Director of ModiQuest Research BV Canada NewsWire VICTORIA, BC, March 15, 2019 VICTORIA, BC , March 15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OT...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...